New antiviral drugs in development could offer the strongest line of defense yet against COVID-19 and other coronaviruses, ...
A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical ...
The University of Arizona and pharmaceutical company Sunshine Biopharma are developing medical technology to minimize the ...
Matthew Taylor likened his recently published work alongside doctoral student Gary Dunn to kicking over a rock. Once the ...
Italy's main medicines regulator gave the go-ahead on Tuesday for human clinical trials on raloxifene, a generic osteoporosis drug that researchers hope may also help reduce COVID-19 symptoms and make ...
Sunshine Biopharma (SBFM) has developed a new series of orally active, non-covalent protease inhibitors with dose-dependent antiviral activity in ...
Johnson & Johnson said on Thursday its experimental coronavirus vaccine prevented hamsters from getting severely ill, as the drugmaker seeks to begin large, late-stage studies in humans later this ...
El Mundo on MSN
Identifying the two mutations that have helped the avian flu virus become more dangerous in North America
These changes in its genome favor the virus's ability to spread and adapt to mammals, such as cows. In March 2024, an outbreak of avian flu was first detected in dairy cows, specifically on farms in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback